bibliographic resource 5913921 [br/5913921]
https://w3id.org/oc/corpus/br/5913921

is a
title
  • A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer
publication date
  • 2012-01-01
contributor
format
identifier
part of